BALDUZZI, Sara
 Distribuzione geografica
Continente #
NA - Nord America 5.045
EU - Europa 2.436
AS - Asia 1.734
SA - Sud America 302
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 9.560
Nazione #
US - Stati Uniti d'America 4.985
GB - Regno Unito 899
SG - Singapore 537
CN - Cina 507
IT - Italia 406
HK - Hong Kong 271
SE - Svezia 266
BR - Brasile 251
DE - Germania 201
IE - Irlanda 171
VN - Vietnam 125
RU - Federazione Russa 93
UA - Ucraina 83
FR - Francia 67
FI - Finlandia 63
TR - Turchia 48
ID - Indonesia 47
IN - India 42
KR - Corea 41
BG - Bulgaria 35
CA - Canada 32
NL - Olanda 27
BE - Belgio 24
MX - Messico 19
JP - Giappone 18
AR - Argentina 17
ES - Italia 14
PL - Polonia 13
ZA - Sudafrica 13
AT - Austria 11
BD - Bangladesh 11
LT - Lituania 10
GR - Grecia 9
MK - Macedonia 9
MY - Malesia 9
PH - Filippine 9
PK - Pakistan 8
CL - Cile 7
EC - Ecuador 7
JO - Giordania 7
VE - Venezuela 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
DK - Danimarca 6
IL - Israele 6
NP - Nepal 6
UZ - Uzbekistan 6
IQ - Iraq 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
BH - Bahrain 4
CO - Colombia 4
IR - Iran 4
KE - Kenya 4
MA - Marocco 4
PY - Paraguay 4
RO - Romania 4
BO - Bolivia 3
CY - Cipro 3
DZ - Algeria 3
NO - Norvegia 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BN - Brunei Darussalam 2
BW - Botswana 2
EE - Estonia 2
ET - Etiopia 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LY - Libia 2
OM - Oman 2
PE - Perù 2
RS - Serbia 2
TN - Tunisia 2
AD - Andorra 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
BB - Barbados 1
BS - Bahamas 1
BZ - Belize 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
GP - Guadalupe 1
HN - Honduras 1
IM - Isola di Man 1
IS - Islanda 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
MD - Moldavia 1
PA - Panama 1
PT - Portogallo 1
SN - Senegal 1
TJ - Tagikistan 1
TM - Turkmenistan 1
ZM - Zambia 1
Totale 9.560
Città #
Southend 661
Fairfield 582
Santa Clara 467
Ashburn 458
Singapore 367
Woodbridge 327
Chandler 311
Hong Kong 269
Houston 233
Seattle 214
Ann Arbor 192
Wilmington 176
Dublin 170
Dearborn 162
Cambridge 160
Nyköping 147
Beijing 144
Jacksonville 126
London 105
Hefei 103
New York 83
Chicago 82
Los Angeles 79
Modena 75
San Diego 52
Dallas 51
The Dalles 41
Ho Chi Minh City 40
Jakarta 39
Munich 37
Shanghai 37
Bologna 36
Princeton 35
Hanoi 34
Sofia 34
Council Bluffs 32
Eugene 32
Moscow 32
Helsinki 31
Redwood City 28
São Paulo 28
Boardman 27
Milan 27
Salt Lake City 27
Seoul 27
Elk Grove Village 23
Izmir 22
Brussels 20
Buffalo 20
Columbus 20
Bremen 19
Rome 19
Fremont 18
Tampa 18
San Francisco 17
Turin 15
Frankfurt am Main 14
Dong Ket 13
Norwalk 13
Phoenix 12
Sterling 12
Warsaw 12
Brooklyn 11
Tokyo 11
Paris 10
Redondo Beach 10
Reggio Emilia 10
Mexico City 9
Ottawa 9
Seongnam 9
Turku 9
Hillsboro 7
Istanbul 7
Nanjing 7
Rio de Janeiro 7
Toronto 7
Amman 6
Amsterdam 6
Atlanta 6
Brasília 6
Changchun 6
Cleveland 6
Falls Church 6
Guangzhou 6
Montreal 6
San Jose 6
Stockholm 6
Biên Hòa 5
Carpi 5
Chennai 5
Curitiba 5
Johannesburg 5
Kent 5
Kilburn 5
Miami 5
Monza 5
Orem 5
Poplar 5
Roggiano Gravina 5
Tashkent 5
Totale 6.961
Nome #
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 427
Indicators of Complex Care During the Consultation-Liaison Psychiatry Activity at the Transplant Center of the Policlinico Hospital, Modena 396
Non-steroid agents for idiopathic pulmonary fibrosis 386
Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients 360
The impact of shift work on the psychological and physical health of nurses in a general hospital: a comparison between rotating night shifts and day shifts 359
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 350
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study. 337
Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson's Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial 310
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: Results of the phase III multicentric Italian study Short-HER 304
Short-term and long-term effects of tibolone in postmenopausal women 303
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 294
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial . 294
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer. 273
"the More the Better" Paradox of Antenatal Ultrasound Examinations in Low-Risk Pregnancy 271
3* Final analysis of the phase III multicentric Italian study Short-HER: 9 weeks vs 1 year adjuvant trastuzumab for HER2+ early breast cancer 265
Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV 264
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 258
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis 254
Home Oxygen Saturation Monitoring And Quality Of Life Evaluation In Patients With Idiopathic Pulmonary Fibrosis: Preliminary Results From A Prospective Multicenter Trial 251
Safety and efficacy of T-DM1 in HER2 positive metastatic breast cancer patients: a real word experience. 247
Systematic review of maternal voice interventions demonstrates increased stability in preterm infants 240
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 236
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 236
Quantiferon-TB Gold In-Tube Tests In Hospital Health Care Workers: A Five Years Experience 234
9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio 225
Trastuzumab containing regimens for early breast cancer. 224
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 221
Short and long term effects of tibolone in postmenopausal women 209
Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients . 209
Trastuzumab-containing regimens for metastatic breast cancer 207
Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis 197
Effectiveness of support groups to improve the quality of life of people with idiopathic pulmonary fibrosis a pre-post test pilot study 194
Repeated Quantiferon-TB Gold In-Tube Tests In Routine Clinical Practice: A Five Years Experience 186
Erlotinib for advanced pancreatic cancer 150
Outpatient parents' views on shared-decision-making at an Italian children's hospital 129
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer 120
Pattern of distant relapse according to intrinsic molecular subtype in patients with HER2-positive breast cancer: a combined analysis of ShortHER, CherLOB, and two institutional cohorts 112
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2â € "Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial 107
Totale 9.639
Categoria #
all - tutte 36.692
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.692


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021698 0 0 0 0 0 86 88 129 79 157 115 44
2021/2022819 46 47 97 43 27 49 33 57 91 82 157 90
2022/20231.033 95 123 72 92 94 100 26 94 261 13 18 45
2023/2024622 21 28 46 53 103 59 80 63 23 39 43 64
2024/20251.858 57 25 38 110 371 321 148 117 170 76 179 246
2025/20261.709 235 101 260 377 654 82 0 0 0 0 0 0
Totale 9.639